Axe Compute Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Axe Compute Inc. (NASDAQ: AGPU) announced that its Compensation Committee approved the grant of options to purchase 100,000 shares of common stock to three newly hired non-executive employees as hiring incentives. The options were granted on October 15, 2026, with an exercise price of $8.60 per share and a ten-year term, vesting over a three-year period subject to continued employment.

10/21/2026, 5:00 PM • GlobeNewswire

Axe Compute (NASDAQ: AGPU) to Ring the Nasdaq Stock Market Opening Bell on October 12, 2026

Axe Compute Inc. (NASDAQ: AGPU) celebrated a milestone by ringing the Nasdaq Opening Bell on October 12, 2026, marking significant commercial momentum in its AI infrastructure business. The company has secured over $3.45 billion in signed contracts in less than a year and continues expanding its dedicated GPU compute capacity, with recent additions including $184 million in customer prepayments and $266 million in new contracts.

10/09/2026, 5:00 PM • GlobeNewswire

Agentic Day Lands in Toronto, Completing a Three-Country, Two-Continent 2026 Series

Agentic Day Canada, an invite-only AI Infrastructure & Investment Summit, takes place July 21-22 at Blockchain Futurist Conference in Toronto. The event brings together AI compute leaders, crypto investors, and infrastructure builders to discuss autonomous AI scaling. It features sessions on AI infrastructure, agentic finance, commerce, and capital, with speakers from Nasdaq-listed Axe Compute, Solana Foundation, and prominent crypto market analysts.

07/20/2026, 3:36 AM • GlobeNewswire

Axe Compute Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

Axe Compute Inc. (NASDAQ: AGPU) announced a $260 million 36-month enterprise contract for dedicated GPU compute capacity, representing approximately $21 million in quarterly revenue once deployed in Q3 2026. The company also appointed Kyle Okamoto as President and Jeremy Yaukey-Witter as CFO. Q1 2026 saw first compute services revenue recognition with a $645k contract liability from customer prepayments, though the company reported a net loss of $7.7 million primarily due to $4.3 million in mark-to-market losses on digital asset holdings.

05/15/2026, 5:59 PM • GlobeNewswire

Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute

Axe Compute (NASDAQ: AGPU) announced the appointment of Christopher Miglino as Chief Executive Officer. Miglino, who previously structured the company's digital asset treasury and facilitated its entry into the AI compute market, will oversee corporate strategy, capital markets initiatives, and decentralized compute operations. The company plans to scale its decentralized GPU compute platform and expand its infrastructure footprint. Miglino received an inducement award of stock options to purchase 500,000 shares with a vesting schedule over three years.

02/09/2026, 8:00 AM • GlobeNewswire

Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy

Predictive Oncology raised $343.5 million through private placements to support a digital asset treasury strategy focused on Aethir's ATH token, aiming to enhance computational capabilities for AI-driven drug discovery.

10/08/2025, 9:00 AM • GlobeNewswire

Nasdaq Jumps 150 Points; US Pending Home Sales Rise

U.S. stocks traded higher with Nasdaq gaining 150 points. Pending home sales surged 4% in August, marking the sharpest gain in five months. Several biotech companies experienced significant stock price movements.

09/29/2025, 10:11 AM • Benzinga

Predictive Oncology Announces 1-for-15 Reverse Stock Split

Predictive Oncology will implement a 1-for-15 reverse stock split on September 30, 2025, to maintain Nasdaq listing compliance by addressing minimum bid price requirements.

09/25/2025, 8:00 AM • GlobeNewswire

Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients

Predictive Oncology and Every Cure are collaborating to use AI platforms for identifying and repurposing existing drugs for cancer treatments, leveraging their respective AI technologies and extensive biobanks to accelerate drug discovery and improve patient outcomes.

09/04/2025, 9:00 AM • GlobeNewswire

PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Law firm Kahn Swick & Foti is investigating the proposed merger between Predictive Oncology and Renovaro, questioning whether the transaction adequately values the company.

08/19/2025, 9:44 PM • GlobeNewswire

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Predictive Oncology reported a Q2 2025 loss of $2.0 million while advancing its ChemoFx cancer treatment selection technology, developing liver toxicity models for Labcorp, and exploring drug repurposing strategies.

08/14/2025, 7:00 AM • GlobeNewswire